Image de couverture de livre

Late Cardiac Toxicity After Anthracyclines and Radiotherapy for Lymphoma—A Regression Analysis of Dose‐Response

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lotte Nygård, Ivan Richter Vogelius, Klaus F. Kofoed, Søren Bentzen, Lena Specht
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Hematological Oncology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B‐Cell Lymphoma
par: Juliette Penichoux, et autres
Publié: (2025)

Toxicity and Tolerability of the OEPA/COPDAC Regimen in Children and Adolescents With Hodgkin Lymphoma: A Real‐World Experience
par: Hala Bekhit, et autres
Publié: (2025)

CAR T‐Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real‐World Experiences From a Single Center on the Use of Radiotherapy
par: J.T. Jutzi, et autres
Publié: (2025)

Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi‐Center Real‐Life Study
par: M. Picardi, et autres
Publié: (2024)

Clinicopathological Characteristics of Extranodal Marginal Zone Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT‐Lymphoma) of the Intestine: A Single Center Analysis
par: Oskar Steinbrecher, et autres
Publié: (2024)

Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real‐Life Multicenter Experience. Results From the REDOT_MCL Study
par: Francesca Maria Quaglia, et autres
Publié: (2026)

Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High‐Dose Cytarabine‐Based Chemotherapy as Second‐Line Treatments for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma
par: Yoshikazu Ikoma, et autres
Publié: (2025)

RETRACTION: Burkitt Lymphoma Versus Diffuse Large B‐Cell Lymphoma: A Practical Approach
Publié: (2026)

Post‐CAR T‐Cell Therapy Failure Metabolic Parameters Predict Survival and Response in Large B‐Cell Lymphoma
par: Hazim S. Ababneh, et autres
Publié: (2024)

Peripheral T‐Cell Lymphoma: What's Next?
par: Sang Eun Yoon, et autres
Publié: (2025)

Low‐Dose Golidocitinib for Triple‐Mutant (JAK1/STAT3/TET2) ITLPD‐GI After DLBCL Remission
par: Wenwen Wang, et autres
Publié: (2026)

Current Status of Revisions to the Lugano Classification in Lymphoma
Publié: (2025)

Exploratory Analysis of Practical Predictive Indices for the Efficacy of Mogamulizumab in Patients With Aggressive Adult T‐Cell Leukemia‐Lymphoma
par: Yutaka Shimazu, et autres
Publié: (2025)

Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B‐Cell Lymphoma and Transformed Follicular Lymphoma
par: Rui Sun, et autres
Publié: (2026)

Lifetime Treatment Trajectories of Mantle Cell Lymphoma: Simulation Based Analysis of 20 Years of Real‐World Data
par: Minna Harmanen, et autres
Publié: (2025)

International Cost‐Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced‐Stage Classic Hodgkin's Lymphoma
par: Youwen Zhu, et autres
Publié: (2026)

Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects
par: Emil Kumar, et autres
Publié: (2025)

Lomustine, Etoposide and Cyclophosphamide as Conditioning for Auto‐HCT in Lymphomas
par: Rafaella Cabral Samico, et autres
Publié: (2025)

Breaking Traditions: Evaluating Single Fraction Radiation in Indolent Lymphoma
par: Hazim S. Ababneh, et autres
Publié: (2024)

Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Update on Biology and Treatment
par: Peter Borchmann, et autres
Publié: (2025)

Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian Perspective
par: Giacomo Loseto, et autres
Publié: (2025)

Survival Benefit of Relmacabtagene Autoleucel Versus Usual Care in Relapsed/Refractory Follicular Lymphoma: A Matching‐Adjusted Indirect Analysis
par: Fenghua Gao, et autres
Publié: (2025)

Role of Radiotherapy in the Era of Novel Immune‐Based Treatment Strategies for Multiple Myeloma
par: Tom Schlusemann, et autres
Publié: (2026)

Indolent T‐Cell Lymphoma of the Gastrointestinal Tract Associated With Strongyloides Stercoralis Infection
par: Yue Zhao, et autres
Publié: (2025)

Marginal Zone Lymphoma: Treatment Update With a Focus on Systemic Approaches
par: Sonali M. Smith
Publié: (2025)

Comprehensive Analysis of Single‐Cell and Bulk Transcriptomics Identified Regulatory T‐Cell Features as Predictors of Prognosis in Diffuse Large B‐Cell Lymphoma
par: Yaoli Cui, et autres
Publié: (2025)

Discovery Science highlights from the 17th International Conference on Malignant Lymphoma
par: Gabriela Forestieri, et autres
Publié: (2024)

Advancing Mantle Cell Lymphoma Risk Assessment: Navigating a Moving Target
par: Simone Ferrero, et autres
Publié: (2025)

Knockdown of VDAC1 Promotes Ferroptosis in Diffuse Large B‐Cell Lymphoma
par: Chuanming Lin, et autres
Publié: (2025)

Efferocytosis and M2 Macrophage Polarization Gene Expression Correlates With Relapsed and Refractory Classical Hodgkin Lymphoma Patients: A Multi‐Omic Analysis
par: Juan Quarroz Braghini, et autres
Publié: (2025)

Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B‐Cell Lymphoma
par: Meirav Kedmi, et autres
Publié: (2024)

A SWOT‐Consensus for CAR‐T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
par: Monia Marchetti, et autres
Publié: (2025)

Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance
par: Allison M. Bock, et autres
Publié: (2024)

Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients
par: A. Zduniak, et autres
Publié: (2024)

Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter Study
par: M. Delia, et autres
Publié: (2025)

Causal Associations of Gut Microbiota Species With Lymphoma: A Two‐Sample Mendelian Randomization Study
par: Mei Li, et autres
Publié: (2025)

MerTK is Ectopically Expressed and Affects the Biological Function in Diffuse Large B‐Cell Lymphoma
par: Yan Li, et autres
Publié: (2025)

Adaptation and Performance of the Self‐Report‐Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
par: James R. Cerhan, et autres
Publié: (2025)

Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study
par: John L. Vaughn, et autres
Publié: (2026)

Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First‐Line Chemotherapy in Patients With Lymphoma
par: Charlotte Nørregaard Grønset, et autres
Publié: (2025)